Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1998
03/05/1998WO1998008966A1 Loxoprofen-containing preparation for external use
03/05/1998WO1998008956A2 Use of a mutated macrolide binding protein for the prevention of gvhd
03/05/1998WO1998008941A1 Thiomethylene group-containing aldehyde cysteine and serine protease inhibitors
03/05/1998WO1998008897A1 Polycarboxylic based cross-linked copolymers
03/05/1998WO1998008877A1 Chitosan derivatives, process for producing the same and uses of the same
03/05/1998WO1998008871A1 Glp-1 derivatives
03/05/1998WO1998008864A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE
03/05/1998WO1998008863A1 Enzyme and dna sequence encoding same
03/05/1998WO1998008859A1 Bioconjugates and delivery of bioactive agents
03/05/1998WO1998008856A2 Mirror-symmetrical selection and evolution of nucleic acids
03/05/1998WO1998008855A2 N6 heterocyclic substituted adenosine derivatives
03/05/1998WO1998008853A1 Phosphinic acid amides as matrix metalloprotease inhibitors
03/05/1998WO1998008850A1 Spirocyclic metalloprotease inhibitors
03/05/1998WO1998008849A1 Method for producing epothilones, and intermediate products obtained during the production process
03/05/1998WO1998008847A1 Substituted 6,5-hetero-bicyclic derivatives
03/05/1998WO1998008846A1 Substituted 6,6-hetero-bicyclic derivatives
03/05/1998WO1998008843A1 4-aminoethoxy-indolone derivatives as dopamine d2 agonists
03/05/1998WO1998008841A1 New thiazole derivatives with phosphodiesterase-inhibiting effect
03/05/1998WO1998008840A1 Integrin antagonists
03/05/1998WO1998008838A1 Substituted amine derivatives
03/05/1998WO1998008835A1 Spirocyclic dopamine receptor subtype ligands
03/05/1998WO1998008834A1 Benzylamine derivatives, their preparation and their application in therapeutics
03/05/1998WO1998008831A1 Preventive or remedy for alzheimer's disease
03/05/1998WO1998008829A1 Pharmaceutical compounds
03/05/1998WO1998008827A1 Heterocyclic metalloprotease inhibitors
03/05/1998WO1998008826A1 Piperazino derivatives as neurokinin antagonists
03/05/1998WO1998008825A1 1,4-heterocyclic metalloprotease inhibitors
03/05/1998WO1998008823A1 Heterocyclic metalloprotease inhibitors
03/05/1998WO1998008822A1 1,3-diheterocyclic metalloprotease inhibitors
03/05/1998WO1998008819A1 4-aminoethoxy indolone derivatives
03/05/1998WO1998008818A1 Inhibitors of phospholipase enzymes
03/05/1998WO1998008817A1 4-aminoethoxy indoles as dopamin d2 agonists and as 5ht1a ligands
03/05/1998WO1998008815A1 Substituted cyclic amine metalloprotease inhibitors
03/05/1998WO1998008814A1 Bidentate metalloprotease inhibitors
03/05/1998WO1998008811A1 Cyclic amine derivatives
03/05/1998WO1998008802A1 Inhibitors of cysteine protease
03/05/1998WO1998008797A1 Naphthyl compounds, intermediates, compositions, and methods of use
03/05/1998WO1998008566A1 Manipulations of nitrosative and oxidatives stress in the treatment of disease
03/05/1998WO1998008547A1 Stanozolol-containing percutaneously absorbable preparation
03/05/1998WO1998008546A2 Therapeutic combinations of rar antagonists and rxr agonists and use thereof
03/05/1998WO1998008542A2 Compounds and methods for treatment and diagnosis of mycobacterial infections
03/05/1998WO1998008537A1 Enhanced stimulation of erythropoiesis
03/05/1998WO1998008526A1 Method to obtain oestrogens from mare's urine
03/05/1998WO1998008525A1 Process to obtain oestrogens from mare's urine
03/05/1998WO1998008523A1 Hydrogenous medicament
03/05/1998WO1998008522A1 Multivitamin products useful in achieving autonomic balance
03/05/1998WO1998008521A1 Vitamine preparations for reducing oxygen consumption during physical efforts
03/05/1998WO1998008520A1 Treatment of pain
03/05/1998WO1998008519A1 Chlorofluorocarbon-free mometasone furoate aerosol formulations
03/05/1998WO1998008518A1 Compositions and methods for administering integrin receptor antagonists
03/05/1998WO1998008517A2 Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
03/05/1998WO1998008516A1 Preventives or remedies for diseases induced by hypofunction of nitric oxide synthase (nos)
03/05/1998WO1998008515A1 Tablet with controlled release of alfuzosine chlorydrate
03/05/1998WO1998008514A1 Preventives/remedies for muscle tissue degenerations
03/05/1998WO1998008513A1 Amorphous benzothiophenes, methods of preparation, and methods of use
03/05/1998WO1998008512A1 Methods of increasing sensitivity of an individual to ob protein by upregulating ob protein receptor
03/05/1998WO1998008511A1 Use of 2-phenyl-1, 2-benzisoselenazol-3(2h)-one for producing a pharmaceutical preparation intended for treatment of the alzheimer's disease
03/05/1998WO1998008510A1 Use of inhibitors of pkc for the manufacture of a medicament for the treatment of central nervous system diseases associated with hiv infection
03/05/1998WO1998008509A1 Use of pkc inhibitors for the manufacture of a medicament for the treatment of aids
03/05/1998WO1998008508A1 Use of pkc inhibitors for the manufacture of a medicament for the treatment of htlv-1 infections
03/05/1998WO1998008507A1 Antiparasitic agents
03/05/1998WO1998008506A1 Pharmaceutical compounds
03/05/1998WO1998008505A1 Pharmaceutical compounds
03/05/1998WO1998008504A1 Remedies for allergic dermatitis
03/05/1998WO1998008503A1 Therapeutic methods and compositions involving isoflavones
03/05/1998WO1998008502A1 SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA[b]BENZOFURANS
03/05/1998WO1998008501A1 Use of arachidonic acid and/or docosahexanoic acid for the manufacture of a medicament for the treatment of dyspraxia
03/05/1998WO1998008500A1 Hypertonic arginine compositions and methods
03/05/1998WO1998008499A1 Biocidal compositions
03/05/1998WO1998008498A1 Treatment of spasticity, convulsions by isovaleric acid derivatives cns depressants
03/05/1998WO1998008497A1 Sulfonyl fluorides for the treatment of alzheimer's disease
03/05/1998WO1998008496A1 Lipophilic polyamine esters for the site specific delivery of nitric oxide in pharmaceutical use
03/05/1998WO1998008495A1 Galenic formula with extended release of milnacipran
03/05/1998WO1998008494A1 Methods and compositions for the treatment of bone resorption disorders, including osteoporosis
03/05/1998WO1998008493A1 Use of 5-ht4 antagonists for regulating corticosteroid secretion
03/05/1998WO1998008490A1 Solid coprecipitates for enhanced bioavailability of lipophilic substances
03/05/1998WO1998008481A2 PROCESS AND APPARATUS FOR THE PRODUCTION OF Bi-212 AND A USE THEREOF
03/05/1998WO1998008480A2 Method of using tetracycline compounds for inhibition of nitric oxide production
03/05/1998WO1998008382A1 Nonclassical pyrrolo[2,3-d]pyrimidine antifolates
03/05/1998WO1998004127A3 Transplant solutions containing pyruvate and methods for transplantation
03/05/1998WO1998003158A3 Ephedrine in granular form with a high active substance content
03/05/1998WO1998001554A3 Secreted proteins and polynucleotides encoding them
03/05/1998WO1997047296A3 Compositions comprising vanadium compounds for use in the treatment of proliferative disorders and arthropathies
03/05/1998WO1997046226A3 USE OF INHIBITORS OF THE CELLULAR Na+/H+ EXCHANGER (NHE) FOR PREPARING A MEDICAMENT FOR NORMALIZING SERUM LIPIDS
03/05/1998WO1997044474A3 Viral particles which are masked or unmasked with respect to a cell receptor
03/05/1998WO1997037688A3 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity
03/05/1998DE19729641A1 Antihämolytische liposomale Zubereitung und Verfahren zu deren Herstellung Antihemolytic liposomal preparation and methods for their preparation
03/05/1998DE19636252A1 Synergistic product for treating rheumatic diseases
03/05/1998DE19635883A1 Transdermales therapeutisches System mit einer Östriol enthaltenden Wirkstoffkombination Transdermal therapeutic system with a combination of active ingredients containing estriol
03/05/1998DE19635676A1 Feste geschäumte Wirkstoffzubereitungen Solid foamed active ingredient preparations
03/05/1998CA2670296A1 Method of using tetracycline compounds for inhibition of nitric oxide production
03/05/1998CA2265049A1 Therapeutic methods and compositions involving isoflavones
03/05/1998CA2264715A1 Methods and compositions for the treatment of bone resorption disorders, including osteoporosis
03/05/1998CA2264577A1 Treatment of spasticity, convulsions by isovaleric acid derivatives cns depressants
03/05/1998CA2264297A1 Pharmaceutical compounds
03/05/1998CA2264267A1 Substituted 1,2,3,4-tetrahydro-2-dibenzofuranamines and 2-aminocyclohepta¬b|benzofurans
03/05/1998CA2264266A1 1,3-diheterocyclic metalloprotease inhibitors
03/05/1998CA2264246A1 Catalytic nucleic acid and its medical use
03/05/1998CA2264172A1 Remedies for allergic dermatitis
03/05/1998CA2264131A1 Pharmaceutical composition containing osteogenesis-promoting substance
1 ... 6682 6683 6684 6685 6686 6687 6688 6689 6690 6691 6692 6693 6694 6695 6696 6697 6698 6699 6700 6701 6702 ... 7860